PofoliaShared via Pofolia

BMC Cardiovascular Disorders· 2026Q2

Efficacy and safety of Shenfu injection on sepsis-induced myocardial dysfunction: a meta-analysis and trial sequential analysis

Wei Liu, Ruiyan Ye, Chen Yayong, Tingting Bao et al.

Short summary

Adjunctive Shenfu Injection (SFI) in 10 RCTs (n=691) improved cardiac function markers (lower NT-proBNP and cTnI, higher LVEF) and reduced SIMD incidence (OR=0.44) but did not impact 28-day mortality or hospital stay.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

PharmacologyPharmacology, Toxicology and Pharmaceutics